- Home
- CAMT vs SRRK Comparison
CAMT vs SRRK Comparison
Compare CAMT & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAMT
- SRRK
- Stock Information
- Founded
- CAMT 1987
- SRRK 2012
- Country
- CAMT Israel
- SRRK United States
- Employees
- CAMT N/A
- SRRK N/A
- Industry
- CAMT Electronic Components
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAMT Technology
- SRRK Health Care
- Exchange
- CAMT Nasdaq
- SRRK Nasdaq
- Market Cap
- CAMT 2.7B
- SRRK 2.8B
- IPO Year
- CAMT 2000
- SRRK 2018
- Fundamental
- Price
- CAMT $66.54
- SRRK $29.01
- Analyst Decision
- CAMT Strong Buy
- SRRK Strong Buy
- Analyst Count
- CAMT 9
- SRRK 6
- Target Price
- CAMT $92.44
- SRRK $42.17
- AVG Volume (30 Days)
- CAMT 397.0K
- SRRK 1.1M
- Earning Date
- CAMT 05-13-2025
- SRRK 05-14-2025
- Dividend Yield
- CAMT N/A
- SRRK N/A
- EPS Growth
- CAMT 46.65
- SRRK N/A
- EPS
- CAMT 2.61
- SRRK N/A
- Revenue
- CAMT $450,862,000.00
- SRRK N/A
- Revenue This Year
- CAMT $17.59
- SRRK N/A
- Revenue Next Year
- CAMT $8.58
- SRRK $452.64
- P/E Ratio
- CAMT $25.47
- SRRK N/A
- Revenue Growth
- CAMT 32.63
- SRRK N/A
- 52 Week Low
- CAMT $47.41
- SRRK $6.76
- 52 Week High
- CAMT $140.50
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- CAMT 51.46
- SRRK 42.82
- Support Level
- CAMT $65.09
- SRRK $28.54
- Resistance Level
- CAMT $70.22
- SRRK $31.60
- Average True Range (ATR)
- CAMT 2.46
- SRRK 1.56
- MACD
- CAMT -0.10
- SRRK -0.17
- Stochastic Oscillator
- CAMT 43.83
- SRRK 14.10
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.